Literature DB >> 3928149

Effect of inhibition of polyamine biosynthesis by DL-alpha-difluoromethylornithine on the growth and melanogenesis of B16 melanoma in vitro and in vivo.

P S Sunkara, C C Chang, N J Prakash, P J Lachmann.   

Abstract

The objective of the present study was to investigate the effect of polyamine depletion by alpha-difluoromethylornithine (DFMO), a specific irreversible inhibitor of ornithine decarboxylase, on the growth and differentiation of B16 melanoma cells grown in culture and also as solid tumors in mice. Polyamine depletion by DFMO (2.5 mM) resulted in a complete inhibition of cell growth in culture and a 90% inhibition of viability of melanoma cells as determined by clonogenic assay at the end of 7 days after DFMO treatment. These results indicate that polyamine depletion induced by DFMO is cytotoxic to B16 melanoma cells in culture. Furthermore a 2- to 5-fold increase in tyrosinase activity and 10-fold accumulation of melanine were observed in polyamine depleted cells compared to control cultures. These effects of DFMO could easily be reversed by the addition of putrescine simultaneously with DFMO. Administration of different doses of DFMO in drinking water to B16 melanoma tumor bearing mice also resulted in an increase in tyrosinase activity and a dose dependent inhibition (86-90%) of tumor growth. Although one cannot rule out the possibility of induction of differentiated phenotype as a result of antiproliferative activity of DFMO, the data presented indicate that the unique sensitivity of melanoma to DFMO may be due to a combination of cell growth inhibition and concomitant induction of differentiation upon polyamine depletion. The results of the present study indicate that polyamines play an important role in growth and differentiation of melanoma and also provide an example of inhibition of tumor cell growth by induction of cellular differentiation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3928149

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Contradictory antitumor efficacies produced by the combination of DNA attacking drugs and polyamine antimetabolites.

Authors:  R D Shrestha; S Fujimoto; K Okui
Journal:  Jpn J Surg       Date:  1987-07

2.  Mononuclear cell polyamine content associated with myeloid maturation in patients with leukemia during administration of polyamine inhibitors.

Authors:  A M Maddox; M J Keating; E J Freireich; M K Haddox
Journal:  Invest New Drugs       Date:  1989-07       Impact factor: 3.850

3.  alpha-Difluoromethylornithine inhibits liver metastasis produced by intrasplenic injection of human tumor cells into nude mice.

Authors:  K A Zirvi; K S Dasmahapatra; U Atabek; M A Lyons
Journal:  Clin Exp Metastasis       Date:  1989 Nov-Dec       Impact factor: 5.150

4.  Role of polyamines in the growth of hormone-responsive experimental breast cancer in vivo.

Authors:  A Manni; B Badger; G Luk; C Wright; R Caplan; H Rockette; M Bartholomew; S R Ahmed
Journal:  Breast Cancer Res Treat       Date:  1988-07       Impact factor: 4.872

5.  Polyamine involvement in the secretion and action of TGF-alpha in hormone sensitive human breast cancer cells in culture.

Authors:  I Kim; A Manni; J Lynch; L Demers
Journal:  Breast Cancer Res Treat       Date:  1991-05       Impact factor: 4.872

6.  A novel anticancer treatment for xenoplanted human gastric cancer using polyamine antimetabolites in a low polyamine diet.

Authors:  R D Shrestha; S Fujimoto; K Okui
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

Review 7.  Mechanisms of differentiation in melanoma cells and melanocytes.

Authors:  D C Bennett
Journal:  Environ Health Perspect       Date:  1989-03       Impact factor: 9.031

8.  Targeting ornithine decarboxylase reverses the LIN28/Let-7 axis and inhibits glycolytic metabolism in neuroblastoma.

Authors:  Ann M Lozier; Maria E Rich; Anissa Pedersen Grawe; Anderson S Peck; Ping Zhao; Anthony Ting-Tung Chang; Jeffrey P Bond; Giselle Saulnier Sholler
Journal:  Oncotarget       Date:  2015-01-01

9.  Growth inhibition and differentiation of murine melanoma B16-BL6 cells caused by the combination of cisplatin and caffeine.

Authors:  H Tsuchiya; K Tomita; H Yasutake; Y Ueda; M Tanaka; T Sasaki
Journal:  Jpn J Cancer Res       Date:  1989-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.